Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Hamed Akbari, Reza Tabrizi, Kamran Bagheri Lankarani, et al.
Life Sciences (2020) Vol. 258, pp. 118167-118167
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
Sujan Dhar, K. Vishnupriyan, Sharat Damodar, et al.
Heliyon (2021) Vol. 7, Iss. 2, pp. e06155-e06155
Open Access | Times Cited: 177
Biomarkers for Prognosis and Treatment Response in COVID-19 Patients
Giulia Bivona, Luisa Agnello, Marcello Ciaccio
Annals of Laboratory Medicine (2021) Vol. 41, Iss. 6, pp. 540-548
Open Access | Times Cited: 132
IL-4/IL-13 remodeling pathway of COVID-19 lung injury
Caroline Busatta Vaz de Paula, Marina Luise Viola de Azevedo, Seigo Nagashima, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 108
JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition
Yiming Luo, Madison Alexander, Massimo Gadina, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 4, pp. 911-925
Open Access | Times Cited: 86
Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID‐19—Mechanisms and Therapeutic Targets
Adriana Fodor, Brînduşa Tiperciuc, Cezar Login, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 85
The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study
Atakan Tanaçan, Nuray Yazıhan, Seyit Ahmet Erol, et al.
Cytokine (2021) Vol. 140, pp. 155431-155431
Open Access | Times Cited: 80
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19
Song-Mao Ouyang, Hong-Quan Zhu, Ying-Na Xie, et al.
BMC Infectious Diseases (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation
Pedram Keshavarz, Faranak Rafiee, Hadiseh Kavandi, et al.
Clinical Imaging (2020) Vol. 73, pp. 86-95
Open Access | Times Cited: 75
JAK inhibitors: Ten years after
Francesca Romana Spinelli, Françoise Meylan, John J. O’Shea, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1615-1627
Open Access | Times Cited: 74
Elastase and exacerbation of neutrophil innate immunity are involved in multi‐visceral manifestations of COVID‐19
Jean‐Louis Guéant, Rosa-Maria Guéant-Rodríguez, Julien Fromonot, et al.
Allergy (2021) Vol. 76, Iss. 6, pp. 1846-1858
Open Access | Times Cited: 72
Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
Vinicius Fontanesi Blum, Sérgio Cimerman, James Hunter, et al.
EClinicalMedicine (2021) Vol. 37, pp. 100981-100981
Open Access | Times Cited: 64
Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity
Andreea Buicu, Simona Cernea, Imre Benedek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1545-1545
Open Access | Times Cited: 59
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
Abbas F. Almulla, Thitiporn Supasitthumrong, Chavit Tunvirachaisakul, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 59
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Metabolic Syndrome and COVID-19
Hidekatsu Yanai
Cardiology Research (2020) Vol. 11, Iss. 6, pp. 360-365
Open Access | Times Cited: 64
Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring
Marcelo Borges Cavalcante, Candice Torres de Melo Bezerra Cavalcante, Manoel Sarno, et al.
Journal of Reproductive Immunology (2020) Vol. 143, pp. 103250-103250
Open Access | Times Cited: 57
Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis
Angelo Zinellu, Panagiotis Paliogiannis, Ciriaco Carru, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 668-674
Open Access | Times Cited: 52
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection
Naoki Kaneko, Sandro Satta, Yutaro Komuro, et al.
Stroke (2020) Vol. 52, Iss. 1, pp. 260-270
Open Access | Times Cited: 50
IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19
Rafael Luís Luporini, Joice Margareth de Almeida Rodolpho, Lauro T. Kubota, et al.
Cytokine (2021) Vol. 143, pp. 155507-155507
Open Access | Times Cited: 48
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19
Yangli Liu, Weiping Tan, Haihong Chen, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 45
Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19
Eliza Dąbrowska, Beata Galińska-Skok, Napoleon Waszkiewicz
Life (2021) Vol. 11, Iss. 10, pp. 1056-1056
Open Access | Times Cited: 41
Genetic determinants of COVID-19 severity and mortality: ACE1 Alu 287 bp polymorphism and ACE1, ACE2, TMPRSS2 expression in hospitalized patients
João Locke Ferreira de Araújo, Átila Duque Rossi, Jéssica Maciel de Almeida, et al.
PeerJ (2025) Vol. 13, pp. e18508-e18508
Open Access
Gastrointestinal involvement attenuates COVID-19 severity and mortality
Alexandra E. Livanos, Divya Jha, Francesca Cossarini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 43
Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
Abdolkarim Hosseini, Hadi Esmaeili Gouvarchin Ghaleh, Hossein Aghamollaei, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174193-174193
Open Access | Times Cited: 39
The Role of Immunogenetics in COVID-19
Fanny Pojero, Giuseppina Candore, Calogero Caruso, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2636-2636
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top